At RDDC, our partnership with the life sciences industry is fundamental to advancing equity in rare disease care. By collaborating with biopharmaceutical companies, diagnostic innovators, and research institutions, we are able to co-create solutions that address the unique challenges faced by marginalized populations—challenges like late diagnosis, limited access to novel therapies, and underrepresentation in clinical trials.
©2025 Rare Disease Diversity Coalition. All rights reserved. | Privacy Policy | Contact Us | Site Credits